About Tute Genomics
Tute Genomics is a company based in Los Angeles (United States) founded in 2012 was acquired by PierianDx in October 2016.. Tute Genomics has raised $7.39 million across 4 funding rounds from investors including Tencent, Intermountain Healthcare and Wellfound. Tute Genomics has completed 1 acquisition, including Knome. Tute Genomics operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Tute Genomics
Tute Genomics has successfully raised a total of $7.39M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $868.53 thousand completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $868,532
-
First Round
First Round
(31 Dec 2013)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2015 | Amount | Series A - Tute Genomics | Valuation |
investors |
|
| Jun, 2015 | Amount | Series A - Tute Genomics | Valuation | Intermountain Healthcare , Healthbox | |
| Dec, 2014 | Amount | Series A - Tute Genomics | Valuation | Eurovestech |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tute Genomics
Tute Genomics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Intermountain Healthcare and Wellfound. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage tech investments are directed by Eurovestech across multiple sectors.
|
Founded Year | Domain | Location | |
|
Healthcare startups are accelerated via a five-day program by Healthbox.
|
Founded Year | Domain | Location | |
|
Investments are directed toward early-stage tech startups by Album VC.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tute Genomics
Tute Genomics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Knome. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Human genome interpretation software and services are provided.
|
2007 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Tute Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tute Genomics Comparisons
Competitors of Tute Genomics
Tute Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Therapeutics for aging diseases are developed by targeting senescent cells.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tute Genomics
Frequently Asked Questions about Tute Genomics
When was Tute Genomics founded?
Tute Genomics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Tute Genomics located?
Tute Genomics is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Is Tute Genomics a funded company?
Tute Genomics is a funded company, having raised a total of $7.39M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.3M, raised on Dec 31, 2013.
What does Tute Genomics do?
Tute Genomics offers clinical-grade web-based application, powered by machine learning algorithms that allow researchers and clinicians to analyze, utilize, and interpret human genomes data for scientific discovery and individualized treatment. The companys platform also supports disease gene finding and biomarker discovery, as well as provides machine intelligence, genome management, data filtration for streamlined output, and association analysis. Its platform serves pharmaceuticals and biotechnology companies, genetics laboratories, and research centers.
Who are the top competitors of Tute Genomics?
Tute Genomics's top competitors include Juno Therapeutics, Poseida Therapeutics and Denali Therapeutics.
How many acquisitions has Tute Genomics made?
Tute Genomics has made 1 acquisition, including Knome.
Who are Tute Genomics's investors?
Tute Genomics has 7 investors. Key investors include Tencent, Intermountain Healthcare, Wellfound, PierianDx, and Eurovestech.